Appetite Stimulants: From Medications to Non-Drug Options

An appetite stimulant is any drug, supplement, or strategy used to increase the desire to eat, and the options range from well-studied prescription medications to herbal remedies with far less evidence behind them. The most commonly prescribed pharmaceutical stimulants include megestrol acetate, cyproheptadine, dronabinol, corticosteroids, and mirtazapine, each working through a different brain pathway and suited to different clinical situations. Choosing the right one depends heavily on why appetite has dropped in the first place, because appetite loss driven by cancer, aging, depression, or a chronic illness responds differently to each approach.

Why People Lose Their Appetite

Before reaching for a stimulant, it helps to understand what knocked appetite off course. In cancer, inflammatory molecules act on the brain’s appetite-control centers and shift metabolism in ways that suppress hunger even as the body desperately needs calories.¹ This creates a vicious cycle: the disease burns through energy reserves, inflammation kills the urge to eat, and the resulting weight loss accelerates muscle wasting.

In older adults, appetite loss has an almost absurdly long list of contributors. Taste and smell decline, the stomach empties more slowly, and the brain’s hunger drive weakens with age. Layer on depression, dementia, dental problems, medication side effects, loneliness, and poverty, and it becomes clear why appetite shrinks so reliably in later life.² A zinc deficiency, which is surprisingly common among older people, can further blunt taste perception and drive appetite even lower.³

Depression complicates the picture in a way many people don’t expect. Some depressed individuals eat more, while others eat far less, and the two groups show genuinely different patterns of brain activity. People with depression-related appetite loss show reduced activity in the part of the brain responsible for internal body awareness, while those whose appetite increases show heightened reward-system responses to food.⁴ This means “depression kills appetite” is only half the story, and treating the underlying mood disorder doesn’t automatically fix the eating problem for every patient.

How the Brain Regulates Hunger

Your brain doesn’t generate hunger from a single switch. It integrates signals from hormones, nerve pathways, and nutrient sensors across several systems, and most pharmaceutical appetite stimulants work by pushing one of these systems harder.

The hormone ghrelin is the closest thing the body has to a dedicated hunger signal. Produced mainly by the stomach, ghrelin travels to the brain’s hypothalamus and rapidly fires up the neurons that drive you to seek food.⁵ This happens within minutes, which is why your stomach growling and your brain suddenly fixating on lunch feel almost simultaneous. Several newer appetite-stimulant drugs are specifically designed to mimic ghrelin’s action.

The endocannabinoid system is another major player. Your body naturally produces molecules that bind to the same receptors that cannabis activates, and stimulating those receptors increases appetite while blocking them suppresses it.⁶ This is the biological reason cannabis gives people “the munchies,” and it’s the basis for pharmaceutical cannabinoid stimulants.

A third system involves orexin, a group of brain chemicals produced in the same hypothalamic region that controls feeding. Orexin levels rise during fasting and when blood sugar drops, helping coordinate the transition from sleeping or resting to actively seeking food.⁷ Meanwhile, the vagus nerve acts as a two-way communication highway between the gut and the brain, relaying information about whether the stomach is full or empty. When the vagus nerve’s sensitivity shifts, as it can in obesity, the brain may not accurately register that it’s time to stop or start eating.⁸

Megestrol Acetate

Megestrol acetate is one of the most widely prescribed appetite stimulants, particularly in cancer and HIV-related wasting. It is a synthetic hormone (a progestational agent) that appears to boost appetite through both direct brain effects and by counteracting the inflammatory molecules that suppress hunger in serious illness.⁹ Patients taking it frequently report improved appetite and gain weight, though a significant portion of that weight tends to be fat rather than muscle, which limits how much functional benefit people actually get.

The drug comes with real downsides. It can cause blood clots, fluid retention, and adrenal suppression if used for extended periods. For patients with advanced cancer where quality of life is the priority and the timeline is measured in months, those risks may be acceptable. For someone with a milder or more treatable cause of appetite loss, the risk-benefit calculation looks very different.

Cyproheptadine

Cyproheptadine is an older antihistamine that was discovered, almost by accident, to stimulate appetite as a side effect. A systematic review covering 46 studies found that cyproheptadine produced significant weight gain across a wide range of patient groups, though it showed minimal benefit in people with progressive diseases like HIV and cancer.¹⁰ The most common side effect was mild to moderate drowsiness, which typically faded after the first few days.

The drug has found a particular niche in pediatrics. In children with cystic fibrosis, a condition that creates high caloric demands the child often can’t meet, cyproheptadine produced an average weight gain of about 3.5 kilograms compared to roughly 1.1 kilograms for placebo, along with gains in height, body mass index, and both fat and lean mass.¹¹ It is also used in underweight children without a specific disease diagnosis, where its mild side-effect profile and decades of clinical experience make doctors more comfortable prescribing it than newer agents.

Corticosteroids for Short-Term Appetite Rescue

Corticosteroids like dexamethasone can boost appetite quickly, often within days, but the effect tends to wear off within weeks and the drugs don’t produce lasting weight gain. This makes them a reasonable choice when someone has a short expected timeline and the goal is comfort rather than long-term nutritional recovery. Dexamethasone is the most commonly chosen corticosteroid for this purpose because it causes less fluid retention than alternatives, is easy to dose, and is inexpensive. The typical dose for appetite stimulation is around 4 milligrams per day.

The catch is the well-known side-effect profile of steroids: elevated blood sugar, mood changes, insomnia, muscle weakness with prolonged use, and immune suppression. For a patient in late-stage cancer who wants to enjoy meals during the holidays, a short course makes sense. For someone with months or years of appetite problems ahead, steroids are the wrong tool.

Mirtazapine

Mirtazapine is an antidepressant that has long been informally used to stimulate appetite because weight gain is one of its most consistent side effects. Doctors have prescribed it off-label for appetite loss for years, but formal trial data supporting this use has only recently emerged. A randomized trial in patients with lung cancer and poor appetite found that those taking mirtazapine consumed roughly 380 extra calories per day compared to placebo after four weeks, with increases in protein, carbohydrate, and fat intake.¹² The benefit in fat consumption persisted at eight weeks.

What makes mirtazapine appealing is the two-for-one effect: if the patient’s appetite loss is partly driven by depression, anxiety, or insomnia (all of which mirtazapine addresses), a single medication can tackle multiple problems. It does cause sedation, especially at lower doses, which is either a benefit or a nuisance depending on whether the patient also struggles with sleep. The evidence base for mirtazapine as a standalone appetite stimulant in non-depressed patients is still thin, so it works best when mood symptoms are part of the picture.

Cannabinoid-Based Stimulants and Their Limitations

Dronabinol is a synthetic version of THC, the main psychoactive compound in cannabis. It works by activating cannabinoid receptors in the brain’s appetite and nausea control centers, which both increases hunger and reduces vomiting.¹³ It was originally approved for AIDS-related appetite loss and chemotherapy-induced nausea, and it remains in use for both.

The evidence for cannabinoid-based appetite stimulants in cancer, however, is surprisingly weak. A systematic review comparing cannabinoid drugs (dronabinol, nabilone, and cannabis extract) to placebo or megestrol found that only one out of five trials showed clear appetite-related benefits, and that trial focused on improved taste perception and protein intake rather than overall food consumption or weight gain.¹⁴ In the single head-to-head comparison, dronabinol did not outperform megestrol.

This gap between popular perception and clinical data is worth noting. Many people assume that because cannabis reliably makes healthy people hungry, pharmaceutical versions should be powerful appetite stimulants in sick patients. But cancer-related appetite loss involves inflammatory and hormonal disruptions that a cannabinoid receptor agonist alone may not overcome. Dronabinol can still be useful, particularly when nausea is a major contributor to poor intake, but it’s not the slam-dunk appetite fix its reputation suggests.

Newer Drugs Under Investigation

The most advanced new appetite stimulant is anamorelin, a drug that mimics ghrelin by activating the same receptor. Unlike injected ghrelin, anamorelin is taken as a pill and has a longer duration of action.¹⁵ Clinical trials have shown that it increases lean body mass, improves appetite, and is well tolerated with no significant increase in serious side effects.¹⁶ It has been approved in Japan for cancer cachexia and is under regulatory review in other countries. Anamorelin represents a genuine conceptual advance because it targets the body’s own hunger-signaling hormone rather than using drugs originally designed for other purposes.

An even newer research target is GDF15, a stress-response protein that rises dramatically in cancer and acts on receptors in the hindbrain to suppress food intake, cause nausea, and promote weight loss. Early clinical trials targeting GDF15 have shown that blocking this pathway can increase appetite, support weight gain, and improve physical activity in cancer patients.¹⁷ If these results hold up, anti-GDF15 therapies could become a fundamentally different kind of appetite stimulant, one that works by removing a brake on hunger rather than pressing the accelerator harder.

Non-Drug Strategies

Not every case of poor appetite requires a prescription. Correcting a zinc deficiency, which can cause taste disturbances and reduced appetite, is one of the simplest interventions and is especially relevant in older adults taking multiple medications.¹⁸ A blood test can check zinc levels, and supplementation is cheap and low-risk.

Bitter herbs and digestive bitters have a long folk-medicine history as appetite enhancers, and there is some physiological basis for the practice. Bitter compounds on the tongue trigger a reflexive response that alters blood flow to the stomach in a way that could support digestion and, in theory, prime the body to accept food.¹⁹ This is a far cry from proof that herbal bitters reliably increase appetite in sick patients, but it suggests the tradition isn’t pure superstition, either. For someone whose appetite loss is mild and not driven by a serious underlying disease, trying a small amount of bitter greens or a digestive bitter tincture before meals carries little downside.

Behavioral strategies also matter more than they get credit for. Eating smaller meals more frequently, prioritizing calorie-dense foods over large volumes, making meals social events, and exercising lightly before eating can all nudge intake upward. For older adults living alone, loneliness itself suppresses appetite, and simply eating with other people can help. None of these approaches replace medication in severe cases, but they are additive, and they work alongside any pharmacological stimulant rather than competing with it.

Matching the Stimulant to the Situation

The variety of available options exists because no single appetite stimulant works well for every cause of appetite loss. The choice depends on the underlying problem, expected duration of treatment, the patient’s other symptoms, and acceptable side effects.

Cancer cachexia: Megestrol acetate has the longest track record. Anamorelin is a newer option with a better side-effect profile where it is available. Corticosteroids can bridge a gap when comfort is the priority and the timeframe is short. Mirtazapine may help when depression and insomnia coexist with the appetite problem.
Aging-related appetite loss: Address reversible causes first: dental problems, medication reviews, depression screening, zinc levels, social isolation. Cyproheptadine or mirtazapine may be used when non-drug strategies are not enough.
Underweight children: Cyproheptadine is the most studied pharmacological option, with demonstrated benefits in cystic fibrosis and broader pediatric underweight. Behavioral and nutritional strategies remain the first-line approach.
Depression-related appetite loss: Mirtazapine addresses both the mood disorder and the appetite problem simultaneously. Treating the depression with any effective antidepressant often improves appetite indirectly.
Nausea-driven poor intake: Dronabinol or other anti-nausea medications may be more appropriate than a pure appetite stimulant, since the problem isn’t a lack of hunger but an inability to keep food down.

A doctor choosing a stimulant will also weigh drug interactions, existing conditions, and patient preferences. Someone already on blood thinners, for example, needs to avoid medications that increase clotting risk, which rules out megestrol in some cases. Someone who cannot tolerate sedation may do better with a corticosteroid than with cyproheptadine or mirtazapine. The “best” appetite stimulant is less about which drug has the most impressive trial data and more about which one fits the specific patient.

When Appetite Loss Isn’t the Real Problem

One underappreciated point: what looks like appetite loss sometimes isn’t a lack of hunger at all. Early satiety, where you feel full after a few bites, can be caused by gastroparesis (slow stomach emptying), medication effects, or even a tumor pressing on the stomach. Nausea or chronic pain can make eating unpleasant even when the hunger signal is intact. Taste changes from chemotherapy or zinc deficiency can make food so unappealing that a person avoids it despite feeling hungry.

In each of these cases, an appetite stimulant that works by cranking up the brain’s hunger signal may miss the target entirely. If the stomach isn’t emptying, a drug that makes you hungrier just adds discomfort. If food tastes metallic from chemotherapy, boosting hunger doesn’t fix the taste problem. The most effective treatment is the one that addresses the actual bottleneck in the eating process, whether that’s a prokinetic drug for slow stomach emptying, an anti-nausea medication, a zinc supplement for taste disturbance, or a true appetite stimulant for someone whose hunger signal has genuinely gone quiet.

This is why a thorough evaluation before starting a stimulant matters. The urge to “just take something to eat more” is understandable, especially when weight is dropping and energy is fading. But the drugs work best when the problem they target is actually the one the patient has, and the list of things that can reduce food intake is long enough that skipping the detective work often means treating the wrong cause.